Lori Macomber
Fortune : 774 456 $ au 31/05/2026
Fortune : 774 456 $ au 31/05/2026
Lori Macomber is Chief Financial Officer, Treasurer & Executive VP at Karyopharm Therapeutics, Inc. since 2025.
Former roles include Chief Financial Officer at Legend Biotech Corp.
from 2022 to 2025, Business Unit Controller at AMETEK, Inc. from 2018 to 2019, Controller & Chief Financial Officer-US Region at Cello Health Ltd. from 2017 to 2018, and Assistant VP-Finance Site Leader at Eli Lilly & Co. from 2010 to 2017.
Education includes undergraduate studies at The Pennsylvania State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/02/2026 | 85 105 ( 0,38 % ) | 774 456 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Directeur Financier/CFO | 03/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Directeur Financier/CFO | 02/01/2025 |
| AMETEK, INC. | Corporate Officer/Principal | 01/09/2019 |
| CELLO HEALTH PLC | Comptroller/Controller/Auditor | 01/02/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/04/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
AMETEK, Inc.
AMETEK, Inc. Electrical ProductsProducer Manufacturing Manufactures and supplies electronic instruments and electromechanical devices | Producer Manufacturing |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Cello Health Ltd.
Cello Health Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company whose subsidiaries provides market research and consulting services | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national